(Q35867466)

10 August 2017

1 reference

title

Application of human leukocyte antigen-G expression in the diagnosis of human cancer (English)

1 reference

10 August 2017

Ie-Ming Shih

1

1 reference

10 August 2017

20 February 2007

1 reference

10 August 2017

1 reference

10 August 2017

68

1 reference

10 August 2017

4

1 reference

10 August 2017

272-276

1 reference

Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905833

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905833

Detection of HLA-G5 secreting cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905833

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905833

Detection of soluble HLA-G molecules in plasma and amniotic fluid

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905833

A class I antigen, HLA-G, expressed in human trophoblasts

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905833

Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905833

Secretion of sHLA-G molecules in malignancies

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905833

Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905833

Association of soluble HLA-G plasma levels with HLA-G alleles

22 October 2018

1 reference

12 December 2020

Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma

1 reference

12 December 2020

HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis

1 reference

12 December 2020

HLA-G is a potential tumor marker in malignant ascites

1 reference

12 December 2020

Soluble HLA-G molecules are increased in lymphoproliferative disorders

1 reference

12 December 2020

Diagnostic accuracy of effusion cytology

1 reference

12 December 2020

HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma

1 reference

12 December 2020

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

1 reference

12 December 2020

HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract

1 reference

12 December 2020

Total Soluble HLA Class I and Soluble HLA-G in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

1 reference

12 December 2020

HLA-G expression in gastric cancer

1 reference

12 December 2020

10.1016/J.HUMIMM.2007.01.010

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

PMCID

1905833